Skip to content
Screener

Neogen NEOG EPS (Diluted)

EPS (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.68+9.3%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$4.27+17.6%
Zoetis logo
ZoetisZTS
$1.65+1.2%
Revvity logo
RevvityRVTY
$0.36+2.9%
Merck & Co. logo
Merck & Co.MRK
-$0.54-131%
TEC
Bio-TechneTECH
$0.32+129%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2.49B+140%
Enterprise value$3.12B+71.2%
P/S2.9×+1.7×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Neogen’s 10-Q, filed April 9, 2026.

Filed
Apr 9, 2026, 4:03 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-149599
Line itemThree months ended February 28, 2026Three months ended February 28, 2025Nine months ended February 28, 2026Nine months ended February 28, 2025
Income Tax (Benefit) Expense(3.3)1.2(0.3)(22.1)
Net (Loss) Income$(17.0)$(10.9)$3.4$(479.8)
Net (Loss) Income Per Share
Basic$(0.08)$(0.05)$0.02$(2.21)
Diluted$(0.08)$(0.05)$0.02$(2.21)
Weighted Average Shares Outstanding
Basic217.7217.0217.4216.8
Diluted217.7217.0217.9216.8

Item 1. Interim Condensed Consolidated Financial Statements

FAQ

What is Neogen's EPS (diluted)?
Neogen (NEOG) reported EPS (diluted) of -$0.08 in Q4 2025.
How has Neogen's EPS (diluted) changed year-over-year?
Neogen's EPS (diluted) decreased by 60.0% year-over-year, from -$0.05 to -$0.08.
What is the long-term trend for Neogen's EPS (diluted)?
Over 3 years (2022 to 2025), Neogen's EPS (diluted) has grown at a 123.6% compound annual growth rate (CAGR), from $0.45 to -$5.03.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Neogen's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude